|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 475.2 ILa | -6.01% |
|
-21.27% | +171.39% |
| 20/03 | NRGene Technologies Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 30/01 | NRgene Technologies Ltd. Establishes Supree | CI |
NRGene Technologies Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 2 million compared to USD 3.16 million a year ago. Net loss was USD 5.24 million compared to USD 6.21 million a year ago.
Basic loss per share from continuing operations was USD 0.42 compared to USD 0.5 a year ago. Diluted loss per share from continuing operations was USD 0.42.
| 1st Jan change | Capi. | |
|---|---|---|
| +171.39% | 16.27M | |
| -21.78% | 25.77B | |
| -2.82% | 8.86B | |
| -1.16% | 4.86B | |
| -24.09% | 755M | |
| +0.43% | 516M | |
| -10.16% | 457M | |
| -9.63% | 274M | |
| -19.47% | 234M | |
| -40.87% | 200M |
NRGENE TECHNOLOGIES LTD 